Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?-Reference-Cited by-同舟云学术

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

Published:2004-01 Issue:4 Volume:8 Page:440-447
ISSN:1472-6483
Container-title:Reproductive BioMedicine Online
language:en
Short-container-title:Reproductive BioMedicine Online

Author:

Cheang Kai I,Nestler John E

Publisher

Elsevier BV

Subject

Developmental Biology,Reproductive Medicine,Obstetrics and Gynecology

Reference58 articles.

1. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells;Adashi;Endocrinology,1981

2. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial;Azziz;Journal of Clinical Endocrinology and Metabolism,2001

3. Effects of metformin and rosiglitazone, alone and in combination, in lean women with polycystic ovary syndrome and normal indices of insulin sensitivity;Baillargeon;The Endocrine Society 84th Annual Meeting,2002

4. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin;Balen;Human Reproduction,1993

5. The polycystic ovary syndrome: what does insulin resistance have to do with it?;Ben-Shlomo;Reproductive BioMedicine Online,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Preparation for the Stimulation;Ovulation Stimulation with Gonadotropins;2015

2. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis;REPRODUCTION;2013-10

3. The role of insulin sensitizers and calcium plus vitamin D3 preparations in the combined treatment of polycystic ovary syndrome;Problems of Endocrinology;2013-02-15

4. Les préalables à la stimulation;Pratique de la stimulation ovulatoire par les gonadotrophines;2013

5. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome;Fertility and Sterility;2010-10